BioCentury
ARTICLE | Company News

immatics, University of Texas MD Anderson Cancer Center cancer news

September 28, 2015 7:00 AM UTC

immatics and MD Anderson launched standalone company Immatics US Inc. (Houston, Texas) to develop autologous and allogeneic adoptive cellular therapies to treat tumors. The newco has access to MD Ande...